BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

287 related articles for article (PubMed ID: 12907627)

  • 1. Transcription factor c-Jun activation represses mdr-1 gene expression.
    Miao ZH; Ding J
    Cancer Res; 2003 Aug; 63(15):4527-32. PubMed ID: 12907627
    [TBL] [Abstract][Full Text] [Related]  

  • 2. RRR-alpha-tocopheryl succinate induction of prolonged activation of c-jun amino-terminal kinase and c-jun during induction of apoptosis in human MDA-MB-435 breast cancer cells.
    Yu W; Simmons-Menchaca M; You H; Brown P; Birrer MJ; Sanders BG; Kline K
    Mol Carcinog; 1998 Aug; 22(4):247-57. PubMed ID: 9726817
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The c-Jun NH(2)-terminal protein kinase/AP-1 pathway is required for efficient apoptosis induced by vinblastine.
    Fan M; Goodwin ME; Birrer MJ; Chambers TC
    Cancer Res; 2001 Jun; 61(11):4450-8. PubMed ID: 11389075
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cytotoxicity, apoptosis induction and downregulation of MDR-1 expression by the anti-topoisomerase II agent, salvicine, in multidrug-resistant tumor cells.
    Miao ZH; Tang T; Zhang YX; Zhang JS; Ding J
    Int J Cancer; 2003 Aug; 106(1):108-15. PubMed ID: 12794765
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DNA damage, c-myc suppression and apoptosis induced by the novel topoisomerase II inhibitor, salvicine, in human breast cancer MCF-7 cells.
    Lu HR; Meng LH; Huang M; Zhu H; Miao ZH; Ding J
    Cancer Chemother Pharmacol; 2005 Mar; 55(3):286-94. PubMed ID: 15592835
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endothelin-1-induced cardiac hypertrophy is inhibited by activation of peroxisome proliferator-activated receptor-alpha partly via blockade of c-Jun NH2-terminal kinase pathway.
    Irukayama-Tomobe Y; Miyauchi T; Sakai S; Kasuya Y; Ogata T; Takanashi M; Iemitsu M; Sudo T; Goto K; Yamaguchi I
    Circulation; 2004 Feb; 109(7):904-10. PubMed ID: 14967736
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ketamine inhibits tumor necrosis factor-alpha and interleukin-6 gene expressions in lipopolysaccharide-stimulated macrophages through suppression of toll-like receptor 4-mediated c-Jun N-terminal kinase phosphorylation and activator protein-1 activation.
    Wu GJ; Chen TL; Ueng YF; Chen RM
    Toxicol Appl Pharmacol; 2008 Apr; 228(1):105-13. PubMed ID: 18191973
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differences between drug-sensitive and -resistant human leukemic CEM cells in c-jun expression, AP-1 DNA-binding activity, and formation of Jun/Fos family dimers, and their association with internucleosomal DNA ladders after treatment with VM-26.
    Kim R; Beck WT
    Cancer Res; 1994 Sep; 54(18):4958-66. PubMed ID: 8069863
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulation of human thioltransferase (hTTase) gene by AP-1 transcription factor under oxidative stress.
    Krysan K; Lou MF
    Invest Ophthalmol Vis Sci; 2002 Jun; 43(6):1876-83. PubMed ID: 12036993
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A peptide fragment of ependymin neurotrophic factor uses protein kinase C and the mitogen-activated protein kinase pathway to activate c-Jun N-terminal kinase and a functional AP-1 containing c-Jun and c-Fos proteins in mouse NB2a cells.
    Adams DS; Hasson B; Boyer-Boiteau A; El-Khishin A; Shashoua VE
    J Neurosci Res; 2003 May; 72(3):405-16. PubMed ID: 12692907
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of Cd-induced molecular events prior to cellular damage in primary rat hepatocytes in culture: activation of the stress activated signal protein JNK and transcription factor AP-1.
    Hsiao CJ; Stapleton SR
    J Biochem Mol Toxicol; 2004; 18(3):133-42. PubMed ID: 15252869
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The fusion protein AML1-ETO in acute myeloid leukemia with translocation t(8;21) induces c-jun protein expression via the proximal AP-1 site of the c-jun promoter in an indirect, JNK-dependent manner.
    Elsässer A; Franzen M; Kohlmann A; Weisser M; Schnittger S; Schoch C; Reddy VA; Burel S; Zhang DE; Ueffing M; Tenen DG; Hiddemann W; Behre G
    Oncogene; 2003 Aug; 22(36):5646-57. PubMed ID: 12944913
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of activator protein 1 activation, vascular endothelial growth factor, and cyclooxygenase-2 expression by 15-deoxy-Delta12,14-prostaglandin J2 in colon carcinoma cells: evidence for a redox-sensitive peroxisome proliferator-activated receptor-gamma-independent mechanism.
    Grau R; Iñiguez MA; Fresno M
    Cancer Res; 2004 Aug; 64(15):5162-71. PubMed ID: 15289320
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PACAP and C2-ceramide generate different AP-1 complexes through a MAP-kinase-dependent pathway: involvement of c-Fos in PACAP-induced Bcl-2 expression.
    Aubert N; Falluel-Morel A; Vaudry D; Xifro X; Rodriguez-Alvarez J; Fisch C; de Jouffrey S; Lebigot JF; Fournier A; Vaudry H; Gonzalez BJ
    J Neurochem; 2006 Nov; 99(4):1237-50. PubMed ID: 17026529
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Complex functions of AP-1 transcription factors in differentiation and survival of PC12 cells.
    Leppä S; Eriksson M; Saffrich R; Ansorge W; Bohmann D
    Mol Cell Biol; 2001 Jul; 21(13):4369-78. PubMed ID: 11390664
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oxidized LDL induces transcription factor activator protein-1 in rat mesangial cells.
    Wu ZL; Wang YC; Zhou Q; Ge YQ; Lan Y
    Cell Biochem Funct; 2003 Sep; 21(3):249-56. PubMed ID: 12910478
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mutant human tumor suppressor p53 modulates the activation of mitogen-activated protein kinase and nuclear factor-kappaB, but not c-Jun N-terminal kinase and activated protein-1.
    Gulati AP; Yang YM; Harter D; Mukhopadhyay A; Aggarwal BB; Benzil DL; Whysner J; Albino AP; Murali R; Jhanwar-Uniyal M
    Mol Carcinog; 2006 Jan; 45(1):26-37. PubMed ID: 16267831
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Jun and JNK kinase are activated in thymocytes in response to VM26 and radiation but not glucocorticoids.
    Testolin L; Carson C; Wang Y; Walker PR; Armato U; Sikorska M
    Exp Cell Res; 1997 Feb; 230(2):220-32. PubMed ID: 9024781
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanism of AP-1-mediated gene expression by select organochlorines through the p38 MAPK pathway.
    Frigo DE; Tang Y; Beckman BS; Scandurro AB; Alam J; Burow ME; McLachlan JA
    Carcinogenesis; 2004 Feb; 25(2):249-61. PubMed ID: 14604893
    [TBL] [Abstract][Full Text] [Related]  

  • 20. c-Jun functions as a calcium-regulated transcriptional activator in the absence of JNK/SAPK1 activation.
    Cruzalegui FH; Hardingham GE; Bading H
    EMBO J; 1999 Mar; 18(5):1335-44. PubMed ID: 10064599
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.